You just read:

FDA Accepts HETLIOZ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder

News provided by

Vanda Pharmaceuticals Inc.

Dec 20, 2018, 07:00 ET